LNK |
SH2B3, LNK: SH2B adapter protein 3 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
1.132 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
1.132 |
Evidence |
|
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
1.132 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
1.132 |
Evidence |
|
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
1.132 |
Evidence |
|
FN1 |
IPI00339223 |
EFNA1 |
EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor |
1.132 |
Evidence |
|
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
IL4 |
IL4: Interleukin-4 precursor |
IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
1.132 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.132 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
1.132 |
Evidence |
|
HCK |
IPI00029769 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
MAPK15 |
IPI00395861 |
1.132 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.132 |
Evidence |
|
HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
1.132 |
Evidence |
|
BMX |
IPI00514142 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
AHR |
AHR: Aryl hydrocarbon receptor precursor |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.132 |
Evidence |
|
IFNG |
IFNG: Interferon gamma precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|
TFAP4 |
TFAP4: Transcription factor AP-4 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.132 |
Evidence |
|